RNASEK and ovarian cancer: These eight novel RNASEK transcripts are widely expressed in different types of human cell lines, including brain tumors, lung adenocarcinomas, leukemia, lymphomas, melanoma, normal pancreas, normal embryonic kidney, ovarian cancer, cervical cancer, prostate cancer, renal cell carcinoma, bladder cancer (BCLA), hepatocellular carcinoma, gastric adenocarcinoma, colon cancer, brain tumors, lung adenocarcinoma, normal pancreas, normal embryonic kidney, and neck and head squamous cell carcinoma [5].